ADAMTS3 restricts cancer invasion in models of early breast cancer progression through enhanced fibronectin degradation.

[1]  C. Brisken,et al.  TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression , 2023, npj Breast Cancer.

[2]  R. Grose,et al.  Everybody needs good neighbours: the progressive DCIS microenvironment. , 2023, Trends in cancer.

[3]  C. Thompson,et al.  Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion , 2022, npj Breast Cancer.

[4]  Nadine H. Elowe,et al.  TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease , 2021, bioRxiv.

[5]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[6]  P. Nisticò,et al.  Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology , 2021, Journal of experimental & clinical cancer research : CR.

[7]  M. G. Christiansen,et al.  The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy , 2021, International journal of molecular sciences.

[8]  J. Konen,et al.  Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning , 2020, Science Advances.

[9]  E. Van Obberghen-Schilling,et al.  Shaping Up the Tumor Microenvironment With Cellular Fibronectin , 2020, Frontiers in Oncology.

[10]  U. auf dem Keller,et al.  Post-Translational Modification-Dependent Activity of Matrix Metalloproteinases , 2019, International journal of molecular sciences.

[11]  D. Mosher,et al.  A disintegrin-like and metalloproteinase domain with thrombospondin type 1 motif 9 (ADAMTS9) regulates fibronectin fibrillogenesis and turnover , 2019, The Journal of Biological Chemistry.

[12]  A. Colige,et al.  Proteomic discovery of substrates of the cardiovascular protease ADAMTS7 , 2019, The Journal of Biological Chemistry.

[13]  Kanet Kanjanapradit,et al.  P-cadherin and CD10 Expression to Distinguish between Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast , 2019, Journal of Health Science and Medical Research.

[14]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[15]  Alissa M. Weaver,et al.  Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin , 2017, The Journal of cell biology.

[16]  S. Richon,et al.  Cancer-associated fibroblasts lead tumor invasion through integrin-β3–dependent fibronectin assembly , 2017, The Journal of cell biology.

[17]  K. Alitalo,et al.  Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 , 2017, Scientific Reports.

[18]  James A. Gopsill,et al.  A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer , 2017, Breast Cancer Research.

[19]  D. Edwards,et al.  Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function , 2017, Breast Cancer Research.

[20]  Benjamin Geiger,et al.  A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins , 2017, Scientific Reports.

[21]  N. Smargiasso,et al.  Determination of the substrate repertoire of ADAMTS2, 3, and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF‐β signaling as primary targets , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Megan Troxell,et al.  TUMORIGENESIS AND NEOPLASTIC PROGRESSION Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ Progression , 2015 .

[23]  A. Colige,et al.  ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis , 2015, Angiogenesis.

[24]  A. Colige,et al.  The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[25]  D. Treanor,et al.  Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies , 2015, Oncotarget.

[26]  J. Cuzick,et al.  Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence , 2013, Clinical Cancer Research.

[27]  D G Altman,et al.  The benefits and harms of breast cancer screening: an independent review , 2013, British Journal of Cancer.

[28]  C. Simón,et al.  Cleavage of endometrial α-integrins into their functional forms is mediated by proprotein convertase 5/6. , 2012, Human reproduction.

[29]  Christopher M Overall,et al.  Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates , 2011, Nature Protocols.

[30]  Maeve Mullooly,et al.  The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? , 2011, Clinical Proteomics.

[31]  D. Griggs,et al.  ADAM-8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala(271). , 2009, Arthritis and rheumatism.

[32]  J. Jones,et al.  Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression , 2009, Breast Cancer Research.

[33]  M. Day,et al.  The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor Activation* , 2008, Journal of Biological Chemistry.

[34]  Jill P. Mesirov,et al.  GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..

[35]  C. López-Otín,et al.  Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.

[36]  M. Iruela-Arispe,et al.  ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2 , 2006, The EMBO journal.

[37]  B. Turk.  Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.

[38]  Bircan Erbas,et al.  The natural history of ductal carcinoma in situ of the breast: a review , 2006, Breast Cancer Research and Treatment.

[39]  J. E. Reed,et al.  Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours , 2006, British Journal of Cancer.

[40]  Mina J Bissell,et al.  Myoepithelial cells: good fences make good neighbors , 2005, Breast Cancer Research.

[41]  W. Dupont,et al.  The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐up , 2005, Cancer.

[42]  G. Colditz,et al.  Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy , 2005, Cancer.

[43]  Kenneth M. Yamada,et al.  A specific α5β1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation , 2005, Journal of Cell Science.

[44]  R. Ball,et al.  Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma , 2004, Clinical Cancer Research.

[45]  G. Weskamp,et al.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.

[46]  N. Seidah,et al.  Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage. , 2003, The Biochemical journal.

[47]  H. Jockusch,et al.  The Metalloprotease Disintegrin ADAM8 , 2002, The Journal of Biological Chemistry.

[48]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[49]  J. Bond,et al.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  N. Seidah,et al.  Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7. , 2000, The Biochemical journal.

[51]  R. Coombes,et al.  Separated human breast epithelial and myoepithelial cells have different growth factor requirements in vitro but can reconstitute normal breast lobuloalveolar structure , 1997, Journal of cellular physiology.

[52]  R C Coombes,et al.  Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with Dynabeads. , 1995, Analytical biochemistry.

[53]  J. Bartek,et al.  Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  U. auf dem Keller,et al.  Exploring Extracellular Matrix Degradomes by TMT-TAILS N-Terminomics. , 2019, Methods in molecular biology.

[55]  Kenneth M. Yamada,et al.  ECM degradation assays for analyzing local cell invasion. , 2009, Methods in molecular biology.